Chester County News and Community Website
CHESTERBROOK, PA — Trevena Inc. (Nasdaq: TRVN), a biopharmaceutical company, spotlighted its first-quarter achievements and financial standing, underscoring advancements in its novel treatment for chronic pain and epilepsy and strategic …
Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) this week unveiled promising updates on its clinical trials and financial standing for the first quarter ending March 31, 2024. The company’s …
Cabaletta Bio Reports Promising Advances in Autoimmune Disease Trials, Looks to Future Innovations Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel cancer treatments, reported notable advancements in its first-quarter financial results and clinical trials, including receiving …
Aprea Therapeutics Announces Positive First Quarter Developments and FDA Clearance for Cancer Drug Trials Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on gene therapies for eye diseases, reported its first-quarter financial results for 2024 and provided an update on its …
Ocugen Advances Gene Therapy Trials, Targets 2026 for Key Regulatory Approvals Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) recently shared its first-quarter financials and highlighted recent advancements in its clinical trials. Among the key updates, interim data from its upliFT-D …
Passage Bio Reports Promising Interim Data in FTD-GRN Treatment Trial Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN), a specialty pharmaceutical company, announced its financial results for the first quarter of 2024, showcasing a strong performance with a notable increase in revenue …
Optinose Reports Growth in Q1 and Optimistic Outlook for XHANCE Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently disclosed their financial results for the first quarter of 2024, while also providing an update on their business operations. …
Orchestra BioMed Unveils Q1 2024 Financial Results, Advances Pivotal Studies on Innovative Medical Therapies Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) this week disclosed its first-quarter financial outcomes for 2024, showcasing significant growth and strategic advancements. The company, known for its innovative contract manufacturing …
NEXGEL Reports Double-Digit Revenue Growth Amid Strategic Expansion Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) this week announced promising developments in its first quarter financial and operational update for 2024. The company reported progress on several …
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced a series of achievements and financial milestones for the first quarter ending March 31, 2024. The company’s strides in …
Verrica Pharmaceuticals Reports Growth and Innovation in First Quarter Financial Results Read More